Advertisement
UK markets close in 4 hours 9 minutes
  • FTSE 100

    8,087.15
    +46.77 (+0.58%)
     
  • FTSE 250

    19,698.47
    -20.90 (-0.11%)
     
  • AIM

    754.79
    +0.10 (+0.01%)
     
  • GBP/EUR

    1.1663
    +0.0018 (+0.16%)
     
  • GBP/USD

    1.2511
    +0.0049 (+0.39%)
     
  • Bitcoin GBP

    50,960.64
    -2,139.86 (-4.03%)
     
  • CMC Crypto 200

    1,350.27
    -32.31 (-2.34%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     
  • GOLD FUTURES

    2,341.40
    +3.00 (+0.13%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,951.14
    -137.56 (-0.76%)
     
  • CAC 40

    8,016.48
    -75.38 (-0.93%)
     

Novavax's Revenue Could Fall Even More -- and It's Actually Good News

Pick your favorite of these adjectives, and it will definitely apply to Novavax's (NASDAQ: NVAX) second-quarter update. What's more, Novavax slashed its full-year revenue guidance. Unsurprisingly, Novavax stock crashed on the atrocious, bad, dismal, horrible news.